New inflammatory indexes, based on routinely examined blood parameters, have been proposed, including NLR and GPS: NLR has been found useful in patients with diffuse large B-cell lymphoma at low risk of death [18], whereas an elevated GPS was associated with poorer survival in patients with extranodal natural killer/T-cell lymphoma [19] and in those with diffuse large cell lymphoma treated with R-CHOP [17]. Here, DDIT3 is linked to diffuse large B-cell lymphoma.